Association of chronic musculoskeletal pain with mortality among UK adults: A population-based cohort study with mediation analysis
- PMID: 34825152
- PMCID: PMC8605211
- DOI: 10.1016/j.eclinm.2021.101202
Association of chronic musculoskeletal pain with mortality among UK adults: A population-based cohort study with mediation analysis
Abstract
Background: We aimed to quantify the association between chronic musculoskeletal pain and all-cause mortality, and to investigate the extent to which this association is mediated by physical activity, smoking status, alcohol consumption, and opioid use.
Methods: For this population-based cohort study, we used data from UK Biobank, UK between baseline visit (2006-2010) to 18th December 2020. We assessed the associations between chronic musculoskeletal pain and all-cause mortality using a Cox proportional hazards model. We performed causal mediation analyses to examine the proportion of the association between chronic musculoskeletal pain and all-cause mortality.
Findings: Of the 384,367 included participants, a total of 187,269 participants reported chronic musculoskeletal pain. Higher number of pain sites was associated with increased risk of all-cause mortality compared to having no pain (e.g., four sites vs no site of pain, Hazard Ratio [HR] 1.46, 95% Confidence Interval [CI] 1.35 to 1.57). The multiple mediator analyses showed that the mediating proportions of all four mediators ranged from 53.4% to 122.6%: among participants with two or more pain sites, the effect estimate reduced substantially, for example, HR reduced from 1.25 (95% CI: 1.21 to 1.30; two pain sites) to 1.07 (95% CI: 1.01 to 1.11; two pain sites).
Interpretation: We found that higher number of pain sites was associated with increased risk of all-cause mortality compared to having no pain, and at least half of the association of chronic musculoskeletal pain with increased all-cause mortality may be accounted for by four mediators.
Funding: Twins Research Australia.
© 2021 The Authors.
Conflict of interest statement
Dr Arden reported receiving personal fees from Pfizer/Lilly and Bristows LLP and grants from Merck outside the submitted work. Dr Nassar is supported by Financial Markets for Children and NHMRC. No other disclosures were reported.
Figures
References
-
- Jackson T., Thomas S., Stabile V., Han X., Shotwell M., McQueen K. Prevalence of chronic pain in low-income and middle-income countries: a systematic review and meta-analysis. Lancet. 2015;385(Suppl 2):S10. - PubMed
-
- Nicholas M., Vlaeyen J.W., Rief W., et al. The IASP classification of chronic pain for ICD-11: chronic primary pain. Pain. 2019;160(1):28–37. - PubMed
-
- Picavet H.S., Schouten J.S. Musculoskeletal pain in the Netherlands: prevalences, consequences and risk groups, the DMC(3)-study. Pain. 2003;102(1–2):167–178. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources